In vivo studies using Mmp9−/− mice have demonstrated that MMP9 deficiency is associated with various abnormalities in processes that are relevant for cancer development, such as inflammation, wound healing, and vascular wall remodeling [67,68,69,70,71]. The gene discussed is MMP9; the disease is cancer.